Study finds that people with newly diagnosed HR-negative, HER2-positive breast cancer were more likely to receive timely, guideline concordant treatment and have longer survival in states that participate in Medicaid expansion under the Affordable Care Act.
Source. Authors: Shi KS, Ji X, Jiang C, Ruddy KJ, Castellino SM, Yabroff KR, Han X. Association of Medicaid expansion with timely receipt of treatment and survival among patients with HR-negative, HER2-positive breast cancer. JNCCN. Featured Online Content. 23 Oct 2024. doi:10.6004/jnccn.2024.7041
Survey Reveals Breast Cancer Risk Factors Widely Misunderstood
Source. A national survey from Myriad Genetics Inc., published September 28, 2023
Study Reveals the Impact of Behavioral Health Disorders on Cancer Surgery Outcomes
Source. Katayama, ES, Woldesenbet S, Munir, MM. Effect of behavioral health
disorders on surgical outcomes in cancer patients. J Amer Coll Surg. 2024.
doi:10.1097/XCS.0000000000000954
Actions Patients Say Would Help Them Better Understand Medical Bills
Workplace Challenges Facing Women
Source. Den Houter K, Barry K. The path to gender parity in leadership. Gallup Workplace
The State of Multi-Cancer Early Detection Testing and the Science Behind the Innovation
Discover how this groundbreaking technology is revolutionizing cancer screening. In this video, lead experts, Dr. Elizabeth O’Donnell and Nima Nabavizadeh, discuss the current state of multi-cancer early detection screening; roles of the multidisciplinary team and care coordination across specialties; and the importance of clinical trials and advocacy for policies at the state and federal level.
Interactive Map for Lung Cancer Services in Rural Appalachia
As part of its Rural Appalachian Lung Cancer Screening Initiative, ACCC created this interactive map designed to aid health care providers and public health professionals locate essential services for people who need lung cancer screening or who are living with lung cancer in an underserved region of rural Appalachia.
Two Critical Tests for Better Pancreatic Cancer Treatment Options
With just a 13% survival rate, pancreatic cancer is the third-deadliest cancer type today. Patients with pancreatic cancer who could be matched to a treatment geared to the specific molecular profile of their tumors lived longer, according to a study published in Lancet Oncology. This blog explains the ins and outs of genetic testing and molecular profiling in a way that patients can appreciate and understand.
Developing a Health Equity Playbook
Designing a health equity playbook starts with a deep understanding of the patients you serve. Successful playbooks have components that build on the patient experience, the protocols that are in place to ensure the cancer program is meeting the unique needs of all its patients, and staff education and training on how to best serve those different patient populations. In this podcast episode, CANCER BUZZ speaks with Maria Hernandez, PhD, President and COO of Impact4Health.
Establish Your Own Molecular Tumor Board
Is your cancer center ready to create or access a molecular tumor board? In this on-demand webinar, Optimizing Treatment with Molecular Tumor Boards, learn how Markey Cancer Center at the University of Kentucky successfully developed its multidisciplinary group. This session covers the structure, operations, and key lessons, along with a review of nationally available resources. Learn from a live Q&A to address common challenges